Edaravone dosage form
Edaravone dosage form
The invention belongs to the field of pharmacy, and discloses a novel edaravone dosage form, and a method utilizing edaravone to treat human diseases related with oxidative stress. According to the method, an effective amount of edaravone or pharmaceutical salts thereof is provided to treat the diseases; the bioavailability is improved, the side effect and the treatment cost are reduced, and a best treatment effect is achieved.
Australia
- University of South Australia Australia
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
selected citations
Citations provided by BIP!
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP! 0
Average
Average
Average
Beta
Related to Research communities
This action will publish the selected files and record in Zenodo. Are you sure you want to proceed?